Category NEWS

LG Display Receives UL Solutions Eyesafe Verification for OLED TVs and Monitors

LG Display Receives UL Solutions Eyesafe Verification for OLED TVs and Monitors

LG Display Receives UL Solutions Eyesafe Verification for OLED TVs and Monitors Introduction of the Verification Achievement UL Solutions has announced that LG Display’s organic light-emitting diode (OLED) televisions and monitors are the first to achieve UL Solutions Eyesafe Verification.…

Read MoreLG Display Receives UL Solutions Eyesafe Verification for OLED TVs and Monitors
Vicero Appoints Leading Cancer Immunotherapy Experts to Advisory Board

Vicero Appoints Leading Cancer Immunotherapy Experts to Advisory Board

Vicero, Inc. Appoints Leading Oncologists to Scientific Advisory Board Vicero, Inc., a preclinical-stage biopharmaceutical company focused on developing next-generation VINCOBODIES for immune-mediated diseases, has announced the appointment of two renowned oncologists and immunotherapy experts, Sumit Subudhi, M.D., Ph.D., and Antoni…

Read MoreVicero Appoints Leading Cancer Immunotherapy Experts to Advisory Board
Nature Made® Focuses on Gut Health with Clinically Proven Probiotics for Better Digestive Wellness

Nature Made® Focuses on Gut Health with Clinically Proven Probiotics for Better Digestive Wellness

Nature Made® Launches New Probiotic Innovations to Support Gut Health and Overall Wellness Nature Made®, a trusted leader in vitamins and supplements for over 50 years, is expanding its digestive health portfolio with new, clinically studied probiotic innovations. These new…

Read MoreNature Made® Focuses on Gut Health with Clinically Proven Probiotics for Better Digestive Wellness
VantAI Unveils Neo-1, the First AI Model for

VantAI Unveils Neo-1, the First AI Model for Rewiring Molecular Interactions in Therapeutic Design

VantAI Unveils Neo-1: A Groundbreaking AI Model for Revolutionary Drug Design VantAI, a cutting-edge biotechnology company, has unveiled Neo-1, a pioneering AI model that is set to transform the future of drug development. Announced at the NVIDIA GTC 2025 conference,…

Read MoreVantAI Unveils Neo-1, the First AI Model for Rewiring Molecular Interactions in Therapeutic Design
iECURE to Present Full Data for First Infant Dosed with ECUR-506 in OTC-HOPE Trial at 2025 ACMG Annual Meeting

iECURE to Present Full Data for First Infant Dosed with ECUR-506 in OTC-HOPE Trial at 2025 ACMG Annual Meeting

iECURE Presents Promising Data for ECUR-506 in OTC-HOPE Phase 1/2 Trial at 2025 ACMG Annual Meeting iECURE, Inc., a gene editing company focused on developing mutation-agnostic in vivo gene insertion therapies for liver disorders, has shared encouraging results from the…

Read MoreiECURE to Present Full Data for First Infant Dosed with ECUR-506 in OTC-HOPE Trial at 2025 ACMG Annual Meeting